The Discounted Cash Flow (DCF) valuation of Lansen Pharmaceutical Holdings Ltd (503.HK) is 2.90 HKD. With the latest stock price at 1.79 HKD, the upside of Lansen Pharmaceutical Holdings Ltd based on DCF is 62.0%.
Based on the latest price of 1.79 HKD and our DCF valuation, Lansen Pharmaceutical Holdings Ltd (503.HK) is a buy. buying 503.HK stocks now will result in a potential gain of 62.0%.
| Range | Selected | |
| WACC / Discount Rate | 8.6% - 10.8% | 9.7% |
| Long-term Growth Rate | 0.0% - 1.0% | 0.5% |
| Fair Price | 2.59 - 3.34 | 2.90 |
| Upside | 44.6% - 86.6% | 62.0% |